Mark Fletcher's Net Worth
-$7.11 Thousand
Who is Mark Fletcher?
Mark Fletcher does not have any significant net worth to report based on the numbers we have. This is based on reported shares in GENEREX BIOTECHNOLOGY CORP.
SEC CIK
Mark Fletcher's CIK is 0001229529
Past Insider Trading and Trends
2009 was Mark Fletcher's most active year for acquiring shares with 5 total transactions. Mark Fletcher's most active month to acquire stocks was the month of September. 2016 was Mark Fletcher's most active year for disposing of shares, totalling 4 transactions. Mark Fletcher's most active month to dispose stocks was the month of January. 2008 saw Mark Fletcher paying a total of $231,995.00 for 275,000 shares, this is the most they've acquired in one year. In 2008 Mark Fletcher cashed out on 478,342 shares for a total of $262,876.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENEREX BIOTECHNOLOGY CORP No price found
EVP General Counsel &SecretaryMark Fletcher owns 15,821,836 units of Common Stock.acquired a total of 20,308,929 shares in GENEREX BIOTECHNOLOGY CORP at a cost of $269,983.75, Mark also disposed a total of 228,342 shares of GENEREX BIOTECHNOLOGY CORP equalling to $262,876.72.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 4
| +39.10% | 4.45M |
—
| $4,447.11 | 15.82M |
Feb 16
| |||
Form 4
|
∞
| 14.89M |
—
| $14,890.03 | 10.44M |
Feb 9
| |||
Form 4
|
∞
| 470.73K |
—
| $470.73 | 470.73K |
Oct 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
| +7.52% | 20K |
$0.24 | $4,780.00 | 286.08K |
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20 - Mar 8
| |||
Form 4
| +3.38% | 8.7K |
$0.52 | $4,524.00 | 266.08K |
Jan 4
| |||
Form 4
| +4.04% | 10K |
$0.49 | $4,900.00 | 257.38K |
Nov 13
| |||
Form 4
| +5.26% | 12.36K |
$0.32 | $3,976.88 | 247.38K |
Jan 12
| |||
Form 4
| +11.90% | 25K |
$0.38 | $9,495.00 | 235.02K |
Oct 31
| |||
Form 4
| +11.50% | 21.66K |
$1.02 | -$40,376.72 | 210.02K |
Apr 18
| |||
Form 4
| +1,309.88% | 175K |
—
|
—
| 188.36K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
No matching records found |